










■ Greater than 90% of cases of acute cough  
    illness are non-bacterial. 
    -  Viral etiologies include influenza,  
       parainfluenza, RSV, and adenovirus. 
-  Bacterial agents include Bordatella 
   pertussis, Mycoplasma pneumoniae, 
   and Chlamydophila pneumoniae. 
 
■ The presence of purulent sputum is not  
    predictive of bacterial infection. 
-  >95% of patients with purulent sputum do 
   not have pneumonia (J Chron Di 1984; 




■ Evaluation should focus on excluding 
    severe illness, particularly pneumonia. 
 
Clinical Assessment for 
Pneumonia 
 
■ Pneumonia is unlikely if all of the 
    following findings are absent (JAMA 




Fever ≥ 38C 
Tachypnea ≥ 24 breaths/min 
Tachycardia ≥ 100 beats/min 
Evidence of 
consolidation 




Acute Cough Illness (Acute Bronchitis) 
Acute bronchitis is an acute respiratory infection with a normal chest radiograph that is manifested by cough 
with or without phlegm production that lasts for up to 3 weeks (Chest 2006;129:95S-103S). 
 
Principles apply to the appropriate treatment of cough illness lasting less than 3 weeks in otherwise 
healthy adults.   
Refer to acute cough illness as a “chest cold”  
to reduce patient expectation for antibiotics (Am J Med 2000;108-83). 
P i i l l h i f h ill l i l h 3 k i h i h l h
■ Consider chest radiograph for patients    
    with any of these findings or  cough  
    lasting >3 weeks. 
Treatment 
 
■ Empiric antibiotic treatment is not  
    indicated for acute bronchitis. 
    - Meta-analyses of randomized,  
      controlled trials all concluded that  
      routine antibiotic treatment is not  
      justified (BMJ 1998;316:906; Chest  
      2006;129:95S-103S). 
 
■ If influenza therapy is considered, it    
   should be initiated within 48 hours of    
   symptom onset for clinical benefit. 
   - During the 2005-06 Flu season CDC  
      recommends that neither amantadine nor    
      rimantadine be used for treatment or  
      prevention of influenza A infections  
      because of high levels of resistance  
      (MMWR 2006 Jan 20;55(2):44-6). 
   - Neuramidase inhibitors such as oseltamivir   
      or zanamivir have activity against influenza    
      A and B viruses. 
   - Antiviral therapy reduces symptom duration  
      by approximately 1 day.         
http://www.cdc.gov/flu/professionals/treatment/ 
 
■ If pertussis is suspected, empiric therapy    
    may be initiated while obtaining a  
    diagnostic test for confirmation. 
   - Antibiotic treatment decreases transmission  
      but has little effect on symptom resolution. 
 
■ Over-the-counter cough suppressants   
    have limited efficacy in relief of cough  
    due to acute bronchitis (Chest 2006;  
    129:95S-103S). 
 
 
TIPS TO REDUCE 
ANTIBIOTIC USE 
 
■ Tell patients that anti- 
    biotic use increases the 
    risk of an antibiotic- 
    resistant infection. 
 
■ Identify and validate  
    patient concerns. 
 
■ Recommend specific  
    symptomatic therapy. 
 
■ Spend time answering  
    questions and offer a  
    contingency plan if  
    symptoms worsen. 
 
■ Provide patient education  
    materials on antibiotic  
    resistance. 
 
■ REMEMBER: Effective  
    communication is more  
    important than an  
    antibiotic for patient   
    satisfaction. 
 
■ See www.cdc.gov/   
    getsmart or contact your  
    local health department  
    for more information and 
    patient education   
    materials. 
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